Cargando…
Circulating Tumor Cells in Prostate Cancer
Circulating tumor cells (CTCs) can provide a non-invasive, repeatable snapshot of an individual patient’s tumor. In prostate cancer, CTC enumeration has been extensively studied and validated as a prognostic tool and has received FDA clearance for use in monitoring advanced disease. More recently, C...
Autores principales: | Hu, Brian, Rochefort, Holly, Goldkorn, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875960/ https://www.ncbi.nlm.nih.gov/pubmed/24305656 http://dx.doi.org/10.3390/cancers5041676 |
Ejemplares similares
-
Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
por: Hugen, Cory M., et al.
Publicado: (2017) -
Current status of liquid biopsies for the detection and management of prostate cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2019) -
Telomere and Telomerase Therapeutics in Cancer
por: Xu, Yucheng, et al.
Publicado: (2016) -
Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019) -
Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)